Coherus BioSciences Announces New Employment Inducement Grants
June 22 2022 - 4:30PM
Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq:
CHRS), today announced that effective June 16, 2022, the
compensation committee of the Company’s board of directors granted
options to purchase an aggregate of 409,000 shares of the common
stock of the Company to 16 newly hired employees with a per share
exercise price of $5.86, the closing trading price on the grant
date. One newly-hired Chief level executive was granted options to
purchase 200,000 shares and one Vice President was granted options
to purchase 45,000 shares. 14 non-officer employees were granted
options to purchase an aggregate of 164,000 shares.
The stock options were granted pursuant to the Coherus
BioSciences, Inc. 2016 Employment Commencement Incentive Plan,
which was approved by the Company’s board of directors in June 2016
under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity
grants to induce new employees to enter into employment with the
Company.
Coherus BioSciences Contact Information:
IR Contact
McDavid Stilwell
Coherus BioSciences, Inc.
IR@coherus.com
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Sep 2023 to Sep 2024